Volume 5, Issue 4, October 2019

European Heart Journal – Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723

• Extract
• View article

Cardiovascular pharmacotherapy: a new ESC Handbook comprehensively addresses pharmacological treatment issues for patients with cardiovascular disease

• Extract
• View article

Critical appraisal of the AUGUSTUS trial

• Extract
• View article

VTE and anti-coagulation therapy in cancer patients

• Extract
• View article

External applicability of the COMPASS trial: the Western Denmark Heart Registry

• Abstract
• View article
• Supplementary data

Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54

• Abstract
• View article
• Supplementary data

Ticagrelor in patients with myocardial infarction: is the treatment strategy crystal clear?

• Extract
• View article

Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System

• Abstract
• View article

High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality

• Abstract
• View article
• Supplementary data

Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis

• Abstract
• View article
• Supplementary data

PCSK9 and inflammation: a review of experimental and clinical evidence

• Abstract
• View article

What are the pharmacodynamics of loop diuretics?

• Extract
• View article